#USA #San Diego #Robbins LLP #Stockholder Rights #Picard Medical

Class Action Lawsuit Filed Against Picard Medical, Inc.

Recently, Robbins LLP announced the initiation of a class action lawsuit on behalf of investors who acquired shares of Picard Medical, Inc. (NYSE: PMI) between September 2, 2025, and October 31, 2025. This legal action is significant for those who suffered substantial financial losses due to alleged fraudulent practices linked to the company.

Context of the Lawsuit

Picard Medical specializes in designing, manufacturing, and marketing medical devices. However, serious allegations have emerged suggesting that the company may have engaged in deceptive practices relating to its stock promotion. According to the complaint, there were accusations that Picard was the subject of a fraudulent promotional scheme. This scheme was said to involve the dissemination of misleading information through social media that misrepresented financial facts and utilized impersonated financial professionals to mislead investors.

Moreover, insiders and affiliated individuals reportedly exploited offshore accounts, enabling them to sell shares of the company at inflated prices during the promotion campaign, eventually leading to significant losses for regular investors. Notably, the stock price of Picard Medical plummeted by around 70% on October 24, 2025, dropping from a high of approximately $12 to just $3.99 per share. Currently, shares are trading at around $2, signaling a troubling decline in investor confidence.

Legal Recourse for Shareholders

Current shareholders of Picard Medical who are interested in participating in the lawsuit must file their documents by April 3, 2026, if they wish to serve as lead plaintiffs. A lead plaintiff acts on behalf of all class members, guiding the litigation process. It's important to note that individuals can still be part of the class without actively participating in the case. Those who prefer to be passive participants can remain as absent class members without further involvement.

Robbins LLP operates on a contingency fee basis, meaning shareholders will not incur any fees or expenses unless the case is resolved favorably.

About Robbins LLP

Robbins LLP has a rich history of advocating for shareholder rights since its establishment in 2002. The firm's commitment to helping investors recover their losses stems from a dedication to improving corporate governance and holding company leaders accountable for their actions.

For individuals who are concerned about their investments in Picard Medical, now is the time to explore available options and take the necessary steps towards recovery. To receive updates regarding the lawsuit or to find more about potential settlements, investors can sign up for alerts from Robbins LLP through their Stock Watch service.

In today's complex financial landscape, being informed and proactive is crucial. For assistance, investors can fill out a contact form, reach out to attorney Aaron Dumas, Jr. via email, or call Robbins LLP directly at (800) 350-6003.

Investors should stay vigilant and promptly address any potential issues affecting their investments, especially in light of turbulent market conditions and corporate governance challenges.